Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors

被引:374
作者
Hecht, FM
Grant, RM
Petropoulos, CJ
Dillon, B
Chesney, MA
Tian, H
Hellmann, NS
Bandrapalli, NI
Digilio, L
Branson, B
Kahn, JO
机构
[1] Univ Calif San Francisco, AIDS Program, San Francisco, CA 94110 USA
[2] San Francisco Gen Hosp, AIDS Program, San Francisco, CA 94110 USA
[3] Gladstone Inst Virol & Immunol, San Francisco, CA USA
[4] ViroLog, S San Francisco, CA USA
[5] Ctr Dis Control & Prevent, Atlanta, GA USA
[6] Univ Calif San Francisco, Ctr Aids Prevent Studies, San Francisco, CA USA
关键词
D O I
10.1056/NEJM199807303390504
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:307 / 311
页数:5
相关论文
共 30 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   TRANSMISSION OF ZIDOVUDINE-RESISTANT HIV-1 THROUGH HETEROSEXUAL CONTACTS [J].
ANGARANO, G ;
MONNO, L ;
APPICE, A ;
GIANNELLI, A ;
ROMANELLI, C ;
FICO, C ;
PASTORE, G .
AIDS, 1994, 8 (07) :1013-1014
[3]   Natural variation in HIV-1 protease, gag p7 and p6, and protease cleavage sites within Gag/Pol polyproteins: Amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1 [J].
Barrie, KA ;
Perez, E ;
Lamers, SL ;
Farmerie, WG ;
Dunn, BM ;
Sleasman, JW ;
Goodenow, MM .
VIROLOGY, 1996, 219 (02) :407-416
[4]   HETEROSEXUAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS ASSOCIATED WITH ZIDOVUDINE RESISTANCE [J].
CONLON, CP ;
KLENERMAN, P ;
EDWARDS, A ;
LARDER, BA ;
PHILLIPS, RE .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :411-415
[5]   HIV-1 protease inhibitors - A review for clinicians [J].
Deeks, SG ;
Smith, M ;
Holodniy, M ;
Kahn, JO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (02) :145-153
[6]   BRIEF REPORT - PRIMARY INFECTION WITH ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
ERICE, A ;
MAYERS, DL ;
STRIKE, DG ;
SANNERUD, KJ ;
MCCUTCHAN, FE ;
HENRY, K ;
BALFOUR, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (16) :1163-1165
[7]  
FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
[8]   KINETIC CHARACTERIZATION AND CROSS-RESISTANCE PATTERNS OF HIV-1 PROTEASE MUTANTS SELECTED UNDER DRUG PRESSURE [J].
GULNIK, SV ;
SUVOROV, LI ;
LIU, BS ;
YU, B ;
ANDERSON, B ;
MITSUYA, H ;
ERICKSON, JW .
BIOCHEMISTRY, 1995, 34 (29) :9282-9287
[9]   A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].
Hammer, SM ;
Squires, KE ;
Hughes, MD ;
Grimes, JM ;
Demeter, LM ;
Currier, JS ;
Eron, JJ ;
Feinberg, JE ;
Balfour, HH ;
Dayton, LR ;
Chodakewitz, JA ;
Fischl, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733
[10]  
HECHT FM, 1998, 5 C RETR OPP INF CHI